Objectives: the conditions of obesity and overweight pose a major risk for a number of
comorbidities, including clinical syndromes resulting from atherosclerotic disease. Recent …

Circulating adiponectin concentrations are reduced in obese individuals, and this reduction
has been proposed to have a crucial role in the pathogenesis of atherosclerosis and …

Adiponectin is an adipokine whose biosynthesis is deranged in obesity and diabetes
mellitus, predisposing to atherosclerosis. Evidence suggests that adiponectin has anti …

Background Despite its beneficial role on insulin resistance and atherosclerosis,
adiponectin has been repeatedly reported as an independent positive predictor of …

Context: Low adiponectin concentrations are associated with the presence of an adverse
cardiovascular disease (CVD) risk profile. Objective: We studied the predictive value of …

Context: The adipokine adiponectin has been suggested to protect against coronary artery
disease (CAD). However, studies addressing the association between adiponectin and …

Adipose tissue is now accepted by the scientific and medical community to be a genuine
endocrine organ, in addition to its classical role as an energy store. Adiponectin is one of the …

Context: Despite established insulin-sensitizing and antiatherogenic preclinical effects,
epidemiological investigations of adiponectin have yielded conflicting findings, and its …

Context: Low adiponectin levels predict type 2 diabetes, and one prospective study in men
reported its independent prediction of vascular events. Many observers thus already …

Aim: Adiponectin is a protein produced exclusively by adipocytes with putative insulin‐
sensitizing and anti‐atherogenic properties. This cross‐sectional study investigated the …